Keybanc Issues Sector Weight Recommendation for Alignment Healthcare
On October 11, 2024, Keybanc commenced coverage of Alignment Healthcare (NasdaqGS:ALHC) with a Sector Weight rating.
Analyst Predictions Point to Decrease
As of September 25, 2024, the average one-year price target for Alignment Healthcare is $10.35 per share. Predictions show a range from a low of $7.07 to a high of $12.60. This average target indicates a potential decline of 9.58% from its latest closing price of $11.45 per share.
For those curious about potential gains, our leaderboard highlights companies with the highest price target upside.
Revenue and Earnings Forecasts
Alignment Healthcare is projected to generate annual revenue of $2,128 million, representing a decrease of 4.66%. The estimated non-GAAP earnings per share (EPS) stands at -0.66.
Fund Sentiment Analysis
A total of 268 funds or institutions currently report holdings in Alignment Healthcare, a decrease of 22 owners, or 7.59%, from the previous quarter. The average portfolio weight across all funds dedicated to ALHC is 0.14%, marking an increase of 77.01%. Additionally, total shares held by institutions grew by 2.26% over the last three months, totaling 174,236K shares. 
A put/call ratio of 0.48 suggests a bullish sentiment for ALHC.
General Atlantic holds 60,993K shares, which accounts for 31.88% of the company. This position has remained unchanged in the last quarter.
Warburg Pincus owns 17,923K shares, representing 9.37% ownership, with no change reported in the past quarter.
Deerfield Management Company, L.P. holds 10,901K shares, equating to 5.70% ownership. This marks a significant increase from their previous 8,271K shares, showing a 24.13% rise. Their portfolio allocation in ALHC surged by 98.74% in the past quarter.
T. Rowe Price Investment Management now has 8,033K shares, representing 4.20% ownership. This is a decrease from 8,304K shares, reflecting a decline of 3.37%. However, their overall portfolio allocation in ALHC increased by 57.33% in the last quarter.
FSPHX – Health Care Portfolio has increased its holdings to 5,600K shares, which is 2.93% of the company. Previously, they held 4,482K shares, indicating a rise of 19.96%. Their portfolio allocation grew by 77.91% over the past quarter.
More About Alignment Healthcare
(Company description provided)
Alignment Healthcare delivers tailored healthcare services in the U.S., focusing on seniors and individuals with chronic illnesses. Their Medicare Advantage plans offer personalized care, including clinical coordination, risk management, and technology facilitation. Through Alignment Health Plan, the company collaborates with select health plans to enhance benefits while reducing costs.
Fintel serves as a comprehensive investing research platform for individual investors, traders, financial advisors, and small hedge funds. Our extensive data encompasses global fundamentals, analyst reports, ownership data, fund sentiment, and more. Our exclusive stock picks leverage advanced, backtested quantitative models aimed at optimizing profits.
Click to Learn More
This content was originally published on Fintel.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
